Morphic Holding Inc

NASDAQ:MORF  
26.04
-0.85 (-3.16%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)968.05M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$3.48 Million
Adjusted EPS-$0.83
See more estimates
10-Day MA$27.79
50-Day MA$28.61
200-Day MA$33.89
See more pivots

Morphic Holding Inc Stock, NASDAQ:MORF

35 Gatehouse Drive A2, Waltham, Massachusetts 02451
United States of America
Phone: +1.781.996.0955
Number of Employees: 101

Description

Morphic Holding, Inc. operates as a biopharmaceutical company, which engages in the research and development of oral small-molecule integrin therapeutics. It operates a Morphic integrin technology platform, MInT platform, to create a broad pipeline of programs across a variety of therapeutic areas. The company was founded by Timothy A. Springer in August 2014 and is headquartered in Waltham, MA.